A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 6, 2012, Pages 583-591

  Zhang, Qiu Bo ^a   Chen, Yin Ting ^a   Lian, Guo Da ^a   Qian, Chen Chen ^a   Chen, Shao Jie ^a   Huang, Kai Hong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD PUGH SCORE; CLINICAL ASSESSMENT; DISEASE COURSE; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODEL; MODEL FOR END STAGE LIVER DISEASE SCORE; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870393031     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.04.014     Document Type: Article

References (30)

1. Lucey M.R., Brown K.A., Everson G.T., et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998, 66:956-962.
2. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31:864-871.
3. Brown R.S., Lake J.R. The survival impact of liver transplant in the MELD era, and the future for organ allocation and distribution. Am J Transplant 2005, 5:203-204.
4. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A Model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
5. Forman L.M., Lucey M.R. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001, 33:473-475.
6. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
7. Huo T.I., Wang Y.W., Yang Y.Y., et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007, 27:498-506.
8. Biggins S.W., Kim W.R., Terrauh N.A., et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006, 130:1652-1660.
9. Angelo L., Berhard A., Guido B., et al. An Integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007, 13:1174-1180.
10. Douglas M., Heuman, Souheil G., Abou-assi, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004, 40:802-810.
11. Bosch J., Arroyo V., Betriu A., et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980, 78:92-99.
12. Albillos A., Colombato L.A., Groszmann R.J. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992, 102:931-935.
13. Madhortra R., Mulcahy H.E., Willner I., et al. Prediction of esophageal varices in patients with cirrhosis. J Clin 2002, 34:81-85.
14. Heuman D.M., Abou-Assi S.G., Habib A., et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. J Hepatol 2004, 40:802-810.
15. Huo T.I., Lin H.C., Wu J.C., et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006, 20:188-194.
16. Rimola A., Garcia-Tsao G., Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000, 32:142.
17. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716.
18. Hanley J.A., McNeil B.J. The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
19. Said A., Williams J., Holden J., et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004, 40:897-903.
20. Boursier J., Cesbron E., Tropet A.L., et al. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009, 43:580-585.
21. Huo T.I., Hsia C.Y., Huang Y.H., et al. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems. J Clin Gastroenterol 2009, 43:773-781.
22. Tzeng W.S., Wu R.H., Lin C.Y., et al. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol 2009, 10:481-489.
23. Wiesner R., Edwards E., Freeman R., et al. The United Network for organ sharing liver disease severity score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91.
24. Botta F., Giannini E., Romagnoli P., et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003, 52:134.
25. Salerno F., Merli M., Cazzaniga M., et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002, 36:494.
26. Mitchell R., McDermid J., Mang M.M., et al. MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol 2011, 3:157-163.
27. Delolmo J.A., Pena A., Serram A., et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000, 32:19.
28. Grace N.D., Groszmann R.J., Garcia-Tsao G., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998, 28:868.
29. Blei A.T. Brain edema and portal-systemic encephalopathy. Liver Transpl 2000, 4:S14.
30. Huo T.I., Wu J.C., Lin H.C., et al. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transpl 2004, 10:1507.